Innoventric (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 29, 2024
- Vertical
- Medtech
- Funding URL
- View Funding Page
- Funding Amount:
- $28,500,000
Company Info
- Company Description
- Innoventric is an Israeli company that develops transcatheter Tricuspid Regurgitation (TR) treatment, addressing a condition that impairs cardiac blood flow.
- Market
- Healthcare
- Location
- Israel